Abstract
Purpose: We assess the efficacy and safety of intravesical valrubicin for the treatment of carcinoma in situ in patients with failure or recurrence after bacillus Calmette-Guerin (BCG) and who othe...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have